NEW YORK, July 16 (GenomeWeb News) - GenTel BioSurfaces has won five SBIR grants from NIH and NSF this year, totaling $900,000, the Madison, Wis.-based company said this week.
Among other projects, GenTel received funding for developing a chip-based test kit for diagnosing allergy.
The company also said it plans to launch a protein array kit this fall.
GenTel is a spin-off company from the University of Wisconsin-Madison founded in 2000. The company, which currently has ten employees, has been developing biochips for life sciences, pharmaceutical, and diagnostics research.
In April 2003, the company raised $1.65 million in venture financing. An institutional investor purchased GenTel Series A convertible preferred stock following a corporate investment on similar terms in 2001. As part of this investment, GenTel received an additional $200,000 as a Technology Development Loan from the State of Wisconsin.